SB 205, as amended, Corbett. Prescription drugs: labeling.
The Pharmacy Law provides for the licensure and regulation of pharmacists by the California State Board of Pharmacy. Existing law requires every prescription, as defined, to include a legible, clear notice of the condition or purpose for which the drug is prescribed, if requested by the patient. Existing law prohibits a pharmacist from dispensing any prescription unless it is in a specified container that is correctly labeled to include, among other information, the condition or purpose for which the drug was prescribed if the condition or purpose is indicated on the prescription. A violation of the Pharmacy Law is a crime.
This bill would requirebegin delete theend deletebegin insert certain portions of the
requiredend insert information on the prescription labelbegin insert, including the name of the patient or patients,end insert to be printed in at least a 12-point sans serif typeface. Because a violation of this requirement would be a crime, the bill would impose a state-mandated local program.
The California Constitution requires the state to reimburse local agencies and school districts for certain costs mandated by the state. Statutory provisions establish procedures for making that reimbursement.
This bill would provide that no reimbursement is required by this act for a specified reason.
Vote: majority. Appropriation: no. Fiscal committee: yes. State-mandated local program: yes.
The people of the State of California do enact as follows:
Section 4076 of the Business and Professions
2Code is amended to read:
(a) A pharmacist shall not dispense any prescription
4except in a container that meets the requirements of state and
5federal law and is correctly begin deletelabeled, in at least a 12-point sans serif begin insert labeledend insert with all of the following:
6typeface,end delete
7(1) Except where the prescriber or the certified nurse-midwife
8who functions pursuant to a standardized procedure or protocol
9described in Section 2746.51, the nurse practitioner who functions
10pursuant to a standardized procedure described in Section 2836.1
11or protocol, the physician
assistant who functions pursuant to
12Section 3502.1, the naturopathic doctor who functions pursuant
13to a standardized procedure or protocol described in Section
143640.5, or the pharmacist who functions pursuant to a policy,
15procedure, or protocol pursuant to either Section 4052.1 or 4052.2
16orders otherwise, either the manufacturer’s trade name of the drug
17or the generic name and the name of the manufacturer. Commonly
18used abbreviations may be used. Preparations containing two or
19more active ingredients may be identified by the manufacturer’s
20trade name or the commonly used name or the principal active
21ingredients.
22(2) The directions for the use of the drug.
23(3) The name of the patient or patients.
24(4) The name of the
prescriber or, if applicable, the name of the
25certified nurse-midwife who functions pursuant to a standardized
26procedure or protocol described in Section 2746.51, the nurse
27practitioner who functions pursuant to a standardized procedure
28described in Section 2836.1 or protocol, the physician assistant
29who functions pursuant to Section 3502.1, the naturopathic doctor
30who functions pursuant to a standardized procedure or protocol
31described in Section 3640.5, or the pharmacist who functions
32pursuant to a policy, procedure, or protocol pursuant to either
33Section 4052.1 or 4052.2.
34(5) The date of issue.
P3 1(6) The name and address of the pharmacy, and prescription
2number or other means of identifying the prescription.
3(7) The strength of the drug or drugs dispensed.
4(8) The quantity of the drug or drugs dispensed.
5(9) The expiration date of the effectiveness of the drug
6dispensed.
7(10) The condition or purpose for which the drug was prescribed
8if the condition or purpose is indicated on the prescription.
9(11) (A) Commencing January 1, 2006, the physical description
10of the dispensed medication, including its color, shape, and any
11identification code that appears on the tablets or capsules, except
12as follows:
13(i) Prescriptions dispensed by a veterinarian.
14(ii) An exemption from the requirements of this paragraph shall
15be granted to a new drug for the first 120 days that the drug is on
16the market and for the 90 days during which the national reference
17file has no description on file.
18(iii) Dispensed medications for which no physical description
19exists in any commercially available database.
20(B) This paragraph applies to outpatient pharmacies only.
21(C) The information required by this paragraph may be printed
22on an auxiliary label that is affixed to the prescription container.
23(D) This paragraph shall not become operative if the board,
24prior to January 1,
2006, adopts regulations that mandate the same
25labeling requirements set forth in this paragraph.
26(b) The information required by paragraphs (1), (2), (3), (7),
27and (10) of subdivision (a) shall be printed in at least a 12-point
28sans serif typeface.
29(b)
end delete
30begin insert(c)end insert If a pharmacist dispenses a prescribed drug by means of a
31unit dose medication system, as defined by administrative
32regulation, for a patient in a skilled nursing, intermediate care, or
33other health care
facility, the requirements of this section will be
34satisfied if the unit dose medication system contains the
35aforementioned information or the information is otherwise readily
36available at the time of drug administration.
37(c)
end delete
38begin insert(d)end insert If a pharmacist dispenses a dangerous drug or device in a
39health facility, as defined in Section 1250 of the Health and Safety
40Code, it is not necessary to include on individual unit dose
P4 1containers for a specific patient, the name of the certified
2nurse-midwife who functions pursuant to a standardized procedure
3or protocol described in Section 2746.51, the nurse
practitioner
4who functions pursuant to a standardized
procedure described in
5Section 2836.1 or protocol, the physician assistant who functions
6pursuant to Section 3502.1, the naturopathic doctor who functions
7pursuant to a standardized procedure or protocol described in
8Section 3640.5, or the pharmacist who functions pursuant to a
9policy, procedure, or protocol pursuant to either Section 4052.1
10or 4052.2.
11(d)
end delete
12begin insert(e)end insert If a pharmacist dispenses a prescription drug for use in a
13facility licensed pursuant to Section 1250 of the Health and Safety
14Code, it is not necessary to include the information required in
15paragraph (11) of subdivision
(a) when the prescription drug is
16administered to a patient by a person licensed under the Medical
17Practice Act (Chapter 5 (commencing with Section 2000)), the
18Nursing Practice Act (Chapter 6 (commencing with Section 2700)),
19or the Vocational Nursing Practice Act (Chapter 6.5 (commencing
20with Section 2840)), who is acting within his or her scope of
21practice.
No reimbursement is required by this act pursuant to
23Section 6 of Article XIII B of the California Constitution because
24the only costs that may be incurred by a local agency or school
25district will be incurred because this act creates a new crime or
26infraction, eliminates a crime or infraction, or changes the penalty
27for a crime or infraction, within the meaning of Section 17556 of
28the Government Code, or changes the definition of a crime within
29the meaning of Section 6 of Article XIII B of the California
30Constitution.
O
98